• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA CLOSED IV CATHETER SYSTEM; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA CLOSED IV CATHETER SYSTEM; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 383650
Device Problems Leak/Splash (1354); Device Contamination with Chemical or Other Material (2944)
Patient Problems Extravasation (1842); Venipuncture (2129)
Event Date 06/19/2020
Event Type  Injury  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.(b)(4).
 
Event Description
It was reported that redness occurred at the puncture site through the entire length of the bd nexiva¿ closed iv catheter system, causing extravasations that were mainly noticed on the third day of placement.An "x-ray, ct scan, magnet, gastroscopy, and ercp" were performed, antibiotics given, and the catheter was replaced.This complaint was created to capture the 1st of 2 related incidents.The following information was provided by the initial reporter: "redness occurs at the puncture site through the entire lenght of the catheter.Moreover, area outside of the fixative is also red what is supported by the image.Furthermore, they also noticed and monitored extravasations due to the insertion of catheter.These situations mostly arises on third day of the catheter insertion which force nurses to replace the catheter." "x-ray, ct scan, magnet, gastroscopy, ercp, administration of antibiotics.".
 
Manufacturer Narrative
The following fields were updated due to additional information: d.10 device available for eval yes, d.10 returned to manufacturer on: 2020-08-13.Investigation summary bd received an unused 18 gauge nexiva unit from lot 9221847 for evaluation.A review of the device history record (dhr) was performed for the reported lot and no quality issues were found during production.Our quality engineer visually inspected the returned unit and observed no physical/mechanical damage to the returned unit.A reaction to the product could result from contaminated unit.Per the dhr review it was noted that this unit was built, packaged and sterilized per specifications and within compliance.The device also appeared to be unused.Based off the visual inspection and dhr review the engineer was unable to verify the reported defect.Since no defect was found during evaluation a definitive root cause could not be determined.The manufacturing facility has been notified of this incident and the findings.H3 other text : see h.10.
 
Event Description
It was reported that redness occurred at the puncture site through the entire length of the bd nexiva¿ closed iv catheter system, causing extravasations that were mainly noticed on the third day of placement.An "x-ray, ct scan, magnet, gastroscopy, and ercp" were performed, antibiotics given, and the catheter was replaced.This complaint was created to capture the 1st of 2 related incidents.The following information was provided by the initial reporter: "redness occurs at the puncture site through the entire lenght of the catheter.Moreover, area outside of the fixative is also red what is supported by the image from the attachment.Futhermore, they also noticed and monitored extravasations due to the insertion of catheter.These situations mostly arises on third day of the catheter insertion which force nurses to replace the catheter." "x-ray, ct scan, magnet, gastroscopy, ercp, adiministration of antibiotics.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD NEXIVA CLOSED IV CATHETER SYSTEM
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
MDR Report Key10258916
MDR Text Key198786077
Report Number1710034-2020-00440
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
PMA/PMN Number
K183399
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,o
Type of Report Initial,Followup
Report Date 09/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date07/31/2022
Device Catalogue Number383650
Device Lot Number9221847
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/13/2020
Initial Date Manufacturer Received 06/20/2020
Initial Date FDA Received07/10/2020
Supplement Dates Manufacturer Received06/20/2020
Supplement Dates FDA Received09/02/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-